Further reading FcRn blockade in CIDP (ADHERE trial) The Lancet Neurology 2024 #PatientEducation #CIDP #Neuromuscular #EvidenceBasedMedicine Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial thelancet.com To view or add a comment, sign in Platelet Hyperreactivity: A Novel Peripheral Biomarker for Preclinical Alzheimers
Losing the muscle that supports your metabolism and helps you move through life
Hence, the safety associated with copper delivery through the skin needs to be established
This treatment has numerous benefits, including skin whitening, anti-aging, and immune-boosting properties
[DOI] [PMC free article] [PubMed] [Google Scholar] Kometani T, Yoshino I, Miura N, Okazaki H, Ohba T, Takenaka T, Shoji F, Yano T, Maehara Y
Wexler D Initial management of hyperglycemia in adults with type 2 diabetes mellitus: India
